Search Tag: Stent

Cardiology Management

Post-stent Ballooning Doubles Risk of Stroke and Death

2015 07 Jun

Researchers at Johns Hopkins report that while the overall risk of stroke and death is low in patients who undergo carotid stenting, the practice of ballooning the vessel after the wire mesh is inserted can double the risk of death and stroke during or shortly after the procedure. The findings have been published in the Journal of Vascular Surgery. "Ballooning... Read more

Cardiology Management

New Study to Evaluate Biotronik’s Combined Pulsar/Passeo Balloon in Treating SFA

2014 18 Jul

BIOLUX 4EVER Study Aims to Build on Positive Results of BIOLUX P-I and 4EVER TrialsBIOTRONIK, a leading manufacturer of cardio- and endovascular devices, has announced that the first patient has been enrolled in the investigator-initiated BIOLUX 4EVER trial. Given the positive results from each of the previous drug releasing balloon (DRB) and self-expanding... Read more

Cardiology Management

Radial Artery Catheterisation: Safer for Women

2014 15 Jul

Threading a catheter to the heart, in order to clear a blockage or place a stent, is usually performed via the femoral artery in a patients’ groin. In an innovative, less traumatic and much safer alternative, especially for women, the catheter can now be inserted through the wrist in a technique called radial artery catheterisation.     Colin... Read more

Cardiology Management

Effectiveness of Angioplasty Questioned for Treatment of CAD

2013 09 Dec

Stable coronary artery disease (CAD) patients who are neither experiencing a heart attack nor an abnormal stress test, may not be receiving additional benefits from angioplasty for the treatment of their narrowed arteries when compared to drug therapy alone. This was revealed in a recent Stony Brook University School of Medicine cardiologists-led survey... Read more

Cardiology Management

Outcome of Dual Antiplatelet Therapy Following Drug-Releasing Stent Implant Not Tied to Duration

2013 01 Nov

A new study evaluating the effects of short-term (defined as three months) versus long-term (one year) dual anti­platelet therapy shows that the shorter duration treatment does not result in poorer outcomes on certain measures such as death, heart attack, stroke, and bleeding for patients with coronary artery disease or low-risk acute coronary syndromes... Read more

Cardiology Management

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

2013 21 May

Abbott today announced CE Mark in Europe for the XIENCE Xpedition™ 48 Everolimus Eluting Coronary Stent System, the first-of-its-kind treatment for very long blockages in the vessels that supply blood to the heart due to coronary artery disease (CAD). XIENCE Xpedition 48 leverages the proven design and clinical outcomes of the XIENCE family of drug... Read more

Endorsed Companies